Mild Cognitive Impairment
INCLUSION
- Between 50-90 years of age
- History of memory decline with gradual onset and slow progression over the last one year
- If receiving medication for memory loss, the medication has been at a stable dose for the last three months
- Must have a study partner who is with the participant at least 8 hours per week and is willing and able to attend and participate in the study visits
EXCLUSION
- Patients who have received any anti-amyloid therapy (Aducanumab or Lecanemab)
Eligibility Criteria
Mild Cognitive Impairment
Male & Female
Age
50-90 years
Sign Up Form
Thank you for your interest in Participating in one of our clinical trials. See if you may qualify by answering a few short questions. By filling out the interest form below, you consent to being contacted by our patient enrollment specialists via phone, text, or email with more information.